← FDA DRUG APPROVALS

FDA NDA · NDA010209

METI-DERM

Sponsor: SCHERING

APPLICATION
NDA010209
TYPE
NDA
ORIGINAL APPROVAL
1956-02-24
LATEST ACTION
1996-04-26
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

METI-DERMDiscontinued
PREDNISOLONE 0.5% · CREAM · TOPICAL

Approval history

1996-04-26Labeling · Supplement 7AP
1996-04-26Labeling · Supplement 6AP
1982-10-14Labeling · Supplement 8AP
1956-02-24Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →